Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomy

被引:50
作者
Dowdy, SC
Stefanek, M
Hartmann, LC
机构
[1] Mayo Clin & Mayo Fdn, Dept Obstet & Gynecol, Div Gynecol Surg, Rochester, MN 55905 USA
[2] NCI, Div Canc Control & Populat Sci, Behav Res Program, Bethesda, MD 20892 USA
[3] Mayo Clin Canc Ctr, Div Med Oncol, Dept Oncol, Rochester, MN USA
关键词
prophylactic; mastectomy; oophorectomy; breast cancer; ovarian cancer;
D O I
10.1016/j.ajog.2004.04.028
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Investigators have used retrospective and prospective study designs to provide much needed data on the extent of risk reduction after prophylactic oophorectomy and mastectomy in women at increased risk for breast and ovarian cancer. In this publication we identify those women who may wish to consider prophylactic surgery, review data demonstrating the efficacy of prophylactic surgery, and discuss potential surgical complications. We also present data about the frequency of use and psychosocial impact of prophylactic surgery in this typically young group of women. Finally, we provide general treatment guidelines for the practicing clinician. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1113 / 1123
页数:11
相关论文
共 77 条
[1]   OSTEOPOROSIS AFTER OOPHORECTOMY FOR NON-MALIGNANT DISEASE IN PREMENOPAUSAL WOMEN [J].
AITKEN, JM ;
HART, DM ;
ANDERSON, JB ;
LINDSAY, R ;
SMITH, DA ;
SPEIRS, CF .
BRITISH MEDICAL JOURNAL, 1973, 2 (5862) :325-328
[2]   Bone loss in young women with karyotypically normal spontaneous premature ovarian failure [J].
Anasti, JN ;
Kalantaridou, SN ;
Kimzey, LM ;
Defensor, RA ;
Nelson, LM .
OBSTETRICS AND GYNECOLOGY, 1998, 91 (01) :12-15
[3]  
AVERETTE HE, 1993, CANCER, V71, P1629
[4]   A genetic epidemiological study of carcinoma of the fallopian tube [J].
Aziz, S ;
Kuperstein, G ;
Rosen, B ;
Cole, D ;
Nedelcu, R ;
McLaughlin, J ;
Narod, SA .
GYNECOLOGIC ONCOLOGY, 2001, 80 (03) :341-345
[5]  
BELCHETZ PE, 1994, NEW ENGL J MED, V330, P1062
[6]   THE WOMAN AT INCREASED RISK FOR BREAST-CANCER - EVALUATION AND MANAGEMENT STRATEGIES [J].
BILIMORIA, MM ;
MORROW, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (05) :263-278
[7]  
BLOODGOOD JC, 1921, T SO SURG ASS, V34, P223
[8]   Long-term effects of oral contraceptives on ovarian cancer risk [J].
Bosetti, C ;
Negri, E ;
Trichopoulos, D ;
Franceschi, S ;
Beral, V ;
Tzonou, A ;
Parazzini, F ;
Greggi, S ;
La Vecchia, C .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (03) :262-265
[9]   Clinicopathologic features of BRCA-linked and sporadic ovarian cancer [J].
Boyd, J ;
Sonoda, Y ;
Federici, MG ;
Bogomolniy, F ;
Rhei, E ;
Maresco, DL ;
Saigo, PE ;
Almadrones, LA ;
Barakat, RR ;
Brown, CL ;
Chi, DS ;
Curtin, JP ;
Poynor, EA ;
Hoskins, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17) :2260-2265
[10]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930